Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Endothelial dysfunction and metabolic syndrome]

L Martín Jadraque1, J M Mostaza

  • 1Servicio de Coronariopatías, Hospital La Paz, Madrid.

Revista Espanola De Cardiologia
|January 12, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Failure of LDL-C goals achievement and underuse of lipid-lowering therapies in patients at high and very high cardiovascular risk: Spanish subset from the European SANTORINI study.

Revista clinica espanola·2024
Same author

Factors associated with mortality due to SARS-CoV-2 in the population over 75 years of age in the Community of Madrid.

Revista clinica espanola·2022
Same author

[Factors associated with mortality due to SARS-CoV-2 in the population over 75 years of age in the Community of Madrid].

Revista clinica espanola·2022
Same author

Comprehensive management of risk factors in peripheral vascular disease. Expert consensus.

Revista clinica espanola·2021
Same author

Nutritional Risk and Mortality at One Year for Elderly Patients Hospitalized with Nonvalvular Atrial Fibrillation. Nonavasc Registry.

The journal of nutrition, health & aging·2020
Same author

Consensus document for the training of residents in cardiovascular risk.

Revista clinica espanola·2020
Same journal

[Early remote monitoring of pacemaker devices and benefits of this paradigm shift. The FAST REMOTE study].

Revista espanola de cardiologia·2023
Same journal

[Cardiopulmonary exercise test in patients with post SARS-CoV-2 sequelae: need to create a multicenter working group. Response].

Revista espanola de cardiologia·2023
Same journal

[Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management].

Revista espanola de cardiologia·2023
Same journal

[Cardiopulmonary exercise test in patients with post SARS-CoV-2 sequelae: need to create a multicenter working group].

Revista espanola de cardiologia·2023
Same journal

[Environment and cardiovascular health: causes, consequences and opportunities in prevention and treatment].

Revista espanola de cardiologia·2022
Same journal

[Third-degree atrioventricular block associated with the SARS-CoV-2 mRNA vaccine].

Revista espanola de cardiologia·2022
See all related articles

Endothelial dysfunction and insulin resistance frequently occur together, linked by shared cardiovascular risk factors. While direct links exist, their independent clinical significance remains unclear.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Physiopathology

Context:

  • Endothelial dysfunction and insulin resistance are common conditions.
  • Both are linked to numerous cardiovascular risk factors.
  • Their co-occurrence suggests a potential relationship.

Purpose:

  • To explore the relationship between endothelial dysfunction and insulin resistance.
  • To investigate the potential direct pathophysiological mechanisms connecting these two conditions.
  • To assess the clinical significance of an independent link between them.

Summary:

  • Endothelial dysfunction and insulin resistance frequently coexist in patients.
  • Shared cardiovascular risk factors likely contribute to their association.

Related Experiment Videos

  • Direct pathophysiological links are proposed, but their independent clinical relevance is uncertain.

    • Impact:

    • Highlights the complex interplay between vascular health and metabolic status.
    • Suggests potential therapeutic targets for managing cardiovascular risk in patients with insulin resistance.
    • Underscores the need for further research to clarify the independent contribution of these conditions to cardiovascular outcomes.